MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein

被引:196
作者
Eck, M [1 ]
Schmausser, B [1 ]
Haas, R [1 ]
Greiner, A [1 ]
Czub, S [1 ]
MullerHermelink, HK [1 ]
机构
[1] MAX PLANCK INST BIOL, D-7400 TUBINGEN, GERMANY
关键词
D O I
10.1016/S0016-5085(97)70028-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Helicobacter pylori is considered to be involved in the pathogenesis of gastric lymphoma of mucosa-associated lymphoid tissue (MALT) type, Strains expressing the CagA protein (CagA(+) strains) have been strongly associated with severe gastritis, duodenal ulceration, and gastric adenocarcinoma. The aim of this study was to determine the presence of H. pylori as well as incidence of CagA(+) strains in gastric MALT-type lymphoma. Methods: Sera of 68 patients with gastric MALT-type lymphoma (22 with low grade, 36 with high grade, and 10 with secondary high grade) were obtained, and the serological response to CagA was studied by immunoblotting using a purified recombinant CagA protein, a CagA(+) strain, and the corresponding isogenic CagA(-) mutant, Results: Of the patients with MALT-type lymphoma, 98.5% (67 of 68 patients) were H. pylori seropositive. In the only seronegative patient, the bacterium was detected histologically by Warthin-Starry staining. Of the seropositive patients, 95.5% had serum immunoglobulin G antibodies to CagA compared with 67% of an H. pylori-positive control group (33 of 49 patients; P = 0.000037) with chronic active gastritis. Conclusions: These results indicate infection of almost all patients with MALT-type lymphoma by CagA(+) H. pylori strains. Strains expressing the CagA protein seem to play a crucial role in the pathogenesis of gastric MALT-type lymphoma.
引用
收藏
页码:1482 / 1486
页数:5
相关论文
共 35 条
  • [1] Akopyants N. S., 1995, Gut, V37, pA1
  • [2] REGRESSION OF PRIMARY GASTRIC LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TYPE AFTER CURE OF HELICOBACTER-PYLORI INFECTION
    BAYERDORFFER, E
    NEUBAUER, A
    RUDOLPH, B
    THIEDE, C
    LEHN, N
    EIDT, S
    STOLTE, M
    [J]. LANCET, 1995, 345 (8965): : 1591 - 1594
  • [3] BEJI A, 1989, LANCET, V2, P1402
  • [4] BLASER MJ, 1995, CANCER RES, V55, P2111
  • [5] MOLECULAR CHARACTERIZATION OF THE 128-KDA IMMUNODOMINANT ANTIGEN OF HELICOBACTER-PYLORI-ASSOCIATED WITH CYTOTOXICITY AND DUODENAL-ULCER
    COVACCI, A
    CENSINI, S
    BUGNOLI, M
    PETRACCA, R
    BURRONI, D
    MACCHIA, G
    MASSONE, A
    PAPINI, E
    XIANG, ZY
    FIGURA, N
    RAPPUOLI, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) : 5791 - 5795
  • [6] SEROLOGIC DETECTION OF INFECTION WITH CAGA(+) HELICOBACTER-PYLORI STRAINS
    COVER, TL
    GLUPCZYNSKI, Y
    LAGE, AP
    BURETTE, A
    TUMMURU, MKR
    PEREZPEREZ, GI
    BLASER, MJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (06) : 1496 - 1500
  • [7] CHARACTERIZATION OF AND HUMAN SEROLOGIC RESPONSE TO PROTEINS IN HELICOBACTER-PYLORI BROTH CULTURE SUPERNATANTS WITH VACUOLIZING CYTOTOXIN ACTIVITY
    COVER, TL
    DOOLEY, CP
    BLASER, MJ
    [J]. INFECTION AND IMMUNITY, 1990, 58 (03) : 603 - 610
  • [8] HELICOBACTER-PYLORI INDUCED INTERLEUKIN-8 EXPRESSION IN GASTRIC EPITHELIAL-CELLS IS ASSOCIATED WITH CAGA POSITIVE PHENOTYPE
    CRABTREE, JE
    COVACCI, A
    FARMERY, SM
    XIANG, Z
    TOMPKINS, DS
    PERRY, S
    LINDLEY, IJD
    RAPPUOLI, R
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (01) : 41 - 45
  • [9] SYSTEMIC AND MUCOSAL HUMORAL RESPONSES TO HELICOBACTER-PYLORI IN GASTRIC-CANCER
    CRABTREE, JE
    WYATT, JI
    SOBALA, GM
    MILLER, G
    TOMPKINS, DS
    PRIMROSE, JN
    MORGAN, AG
    [J]. GUT, 1993, 34 (10) : 1339 - 1343
  • [10] MUCOSAL IGA RECOGNITION OF HELICOBACTER-PYLORI 120-KDA PROTEIN, PEPTIC-ULCERATION, AND GASTRIC PATHOLOGY
    CRABTREE, JE
    TAYLOR, JD
    WYATT, JI
    HEATLEY, RV
    SHALLCROSS, TM
    TOMPKINS, DS
    RATHBONE, BJ
    [J]. LANCET, 1991, 338 (8763) : 332 - 335